Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA

Marisa M. Fisher, Cristina N. Perez Chumbiauca, Kieren Mather, Raghu Mirmira, Sarah A. Tersey

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Noninvasive detection of early β-cell death in type 1 diabetes might identify individuals in whom therapeutic interventions would preserve β-cell mass and prevent hyperglycemia. Recent studies in mice have shown that βcell death produces a corresponding increase in unmethylated preproinsulin (PPI) DNA in serum. Here, we report the development of a novel assay using dual fluorescent-probe multiplex PCR (TaqMan) to detect differential methylation of circulating PPI DNA. Key assay features include low background signals, linear assay output across a large range of values, and simultaneous detection of methylated and unmethylated PPI DNA in a single reaction. We defined the "unmethylation index" as a summary parameter that reflects the relative amounts of unmethylated vs methylated PPI DNA. To validate this assay's ability to detect β-cell death in vivo, we measured the unmethylation index in the serum of diabetic mouse models, including high- and multiple low-dose streptozotocin-induced diabetes, and the nonobese diabetic mouse model of type 1 diabetes. Our data show a significantly increased unmethylation index concordant with the known timeline of β-cell death that precedes the onset of hyperglycemia. Subsequently, we observed a decrease in the unmethylation index following diabetes development, likely reflecting the absence of further β-cell death in the pancreas. We conclude that simultaneous measurement of methylated and unmethylated PPI DNA using the multiplex PCR method described here is a readily available and sensitive indicator of dying β-cells that may be useful to track diabetes progression and response to therapeutic intervention.

Original languageEnglish
Pages (from-to)3476-3481
Number of pages6
JournalEndocrinology
Volume154
Issue number9
DOIs
StatePublished - Sep 1 2013

Fingerprint

Multiplex Polymerase Chain Reaction
Islets of Langerhans
Cell Death
DNA
Type 1 Diabetes Mellitus
Hyperglycemia
Inbred NOD Mouse
Experimental Diabetes Mellitus
Serum
Fluorescent Dyes
Methylation
Pancreas
preproinsulin
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA. / Fisher, Marisa M.; Perez Chumbiauca, Cristina N.; Mather, Kieren; Mirmira, Raghu; Tersey, Sarah A.

In: Endocrinology, Vol. 154, No. 9, 01.09.2013, p. 3476-3481.

Research output: Contribution to journalArticle

Fisher, Marisa M. ; Perez Chumbiauca, Cristina N. ; Mather, Kieren ; Mirmira, Raghu ; Tersey, Sarah A. / Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA. In: Endocrinology. 2013 ; Vol. 154, No. 9. pp. 3476-3481.
@article{64c5d7e2ec614bcb863787ad6b610f1b,
title = "Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA",
abstract = "Noninvasive detection of early β-cell death in type 1 diabetes might identify individuals in whom therapeutic interventions would preserve β-cell mass and prevent hyperglycemia. Recent studies in mice have shown that βcell death produces a corresponding increase in unmethylated preproinsulin (PPI) DNA in serum. Here, we report the development of a novel assay using dual fluorescent-probe multiplex PCR (TaqMan) to detect differential methylation of circulating PPI DNA. Key assay features include low background signals, linear assay output across a large range of values, and simultaneous detection of methylated and unmethylated PPI DNA in a single reaction. We defined the {"}unmethylation index{"} as a summary parameter that reflects the relative amounts of unmethylated vs methylated PPI DNA. To validate this assay's ability to detect β-cell death in vivo, we measured the unmethylation index in the serum of diabetic mouse models, including high- and multiple low-dose streptozotocin-induced diabetes, and the nonobese diabetic mouse model of type 1 diabetes. Our data show a significantly increased unmethylation index concordant with the known timeline of β-cell death that precedes the onset of hyperglycemia. Subsequently, we observed a decrease in the unmethylation index following diabetes development, likely reflecting the absence of further β-cell death in the pancreas. We conclude that simultaneous measurement of methylated and unmethylated PPI DNA using the multiplex PCR method described here is a readily available and sensitive indicator of dying β-cells that may be useful to track diabetes progression and response to therapeutic intervention.",
author = "Fisher, {Marisa M.} and {Perez Chumbiauca}, {Cristina N.} and Kieren Mather and Raghu Mirmira and Tersey, {Sarah A.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1210/en.2013-1223",
language = "English",
volume = "154",
pages = "3476--3481",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA

AU - Fisher, Marisa M.

AU - Perez Chumbiauca, Cristina N.

AU - Mather, Kieren

AU - Mirmira, Raghu

AU - Tersey, Sarah A.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Noninvasive detection of early β-cell death in type 1 diabetes might identify individuals in whom therapeutic interventions would preserve β-cell mass and prevent hyperglycemia. Recent studies in mice have shown that βcell death produces a corresponding increase in unmethylated preproinsulin (PPI) DNA in serum. Here, we report the development of a novel assay using dual fluorescent-probe multiplex PCR (TaqMan) to detect differential methylation of circulating PPI DNA. Key assay features include low background signals, linear assay output across a large range of values, and simultaneous detection of methylated and unmethylated PPI DNA in a single reaction. We defined the "unmethylation index" as a summary parameter that reflects the relative amounts of unmethylated vs methylated PPI DNA. To validate this assay's ability to detect β-cell death in vivo, we measured the unmethylation index in the serum of diabetic mouse models, including high- and multiple low-dose streptozotocin-induced diabetes, and the nonobese diabetic mouse model of type 1 diabetes. Our data show a significantly increased unmethylation index concordant with the known timeline of β-cell death that precedes the onset of hyperglycemia. Subsequently, we observed a decrease in the unmethylation index following diabetes development, likely reflecting the absence of further β-cell death in the pancreas. We conclude that simultaneous measurement of methylated and unmethylated PPI DNA using the multiplex PCR method described here is a readily available and sensitive indicator of dying β-cells that may be useful to track diabetes progression and response to therapeutic intervention.

AB - Noninvasive detection of early β-cell death in type 1 diabetes might identify individuals in whom therapeutic interventions would preserve β-cell mass and prevent hyperglycemia. Recent studies in mice have shown that βcell death produces a corresponding increase in unmethylated preproinsulin (PPI) DNA in serum. Here, we report the development of a novel assay using dual fluorescent-probe multiplex PCR (TaqMan) to detect differential methylation of circulating PPI DNA. Key assay features include low background signals, linear assay output across a large range of values, and simultaneous detection of methylated and unmethylated PPI DNA in a single reaction. We defined the "unmethylation index" as a summary parameter that reflects the relative amounts of unmethylated vs methylated PPI DNA. To validate this assay's ability to detect β-cell death in vivo, we measured the unmethylation index in the serum of diabetic mouse models, including high- and multiple low-dose streptozotocin-induced diabetes, and the nonobese diabetic mouse model of type 1 diabetes. Our data show a significantly increased unmethylation index concordant with the known timeline of β-cell death that precedes the onset of hyperglycemia. Subsequently, we observed a decrease in the unmethylation index following diabetes development, likely reflecting the absence of further β-cell death in the pancreas. We conclude that simultaneous measurement of methylated and unmethylated PPI DNA using the multiplex PCR method described here is a readily available and sensitive indicator of dying β-cells that may be useful to track diabetes progression and response to therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=84883174104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883174104&partnerID=8YFLogxK

U2 - 10.1210/en.2013-1223

DO - 10.1210/en.2013-1223

M3 - Article

VL - 154

SP - 3476

EP - 3481

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -